Phorbol esters caused reversible decrease in the levels of terminal deoxynucleotidyl transferase (TdT) and adenosine deaminase (ADA) mRNAs and an increase in the level of purine nucleoside phosphorylase (PNP) mRNA. The structural specificity of the phorbol esters affecting ADA, TdT and PNP mRNA levels correlates with their effectiveness in the activation of protein kinase (?KC). The effect of phorbol esters on TdT and ADA mRNA levels is attributed to an apparent decrease in stability of their mRNAs. The changes observed in ADA, TdT and PNF mRNA levels closely simulate the behaviour of these enzyme activities during T-cell differentiation in vivo. Moreover, similar changes in ADA, TdT and PNP activities were observed in immature pre-B and T-lymphoid cell lines expressing TdT activity. The presence of high ADA and low PNP activities in immature lymphocytes may have a role in maintaining balanced intracellular dGTP/dATP pools which are required for TdT activity (Cohen, A. et al. J. Biol. Chem. ?58:12334).
TRANSFERASE mRNA LEVELS BY PHORBOL ESTERS IN HUMAN
THYMOCYTES. a and U Wtinez-Valdez, The Hospital for Sick Children, Division of Inmunology /Rheumatology, Research Institute, Toronto, Ontario Canada. Phorbol esters caused reversible decrease in the levels of terminal deoxynucleotidyl transferase (TdT) and adenosine deaminase (ADA) mRNAs and an increase in the level of purine nucleoside phosphorylase (PNP) mRNA. The structural specificity of the phorbol esters affecting ADA, TdT and PNP mRNA levels correlates with their effectiveness in the activation of protein kinase (?KC). The effect of phorbol esters on TdT and ADA mRNA levels is attributed to an apparent decrease in stability of their mRNAs. The changes observed in ADA, TdT and PNF mRNA levels closely simulate the behaviour of these enzyme activities during T-cell differentiation in vivo. Moreover, similar changes in ADA, TdT and PNP activities were observed in immature pre-B and T-lymphoid cell lines expressing TdT activity. The presence of high ADA and low PNP activities in immature lymphocytes may have a role in maintaining balanced intracellular dGTP/dATP pools which are required for TdT activity (Cohen, A. et al. J. Biol. Chem. ?58:12334) .
Expression of TdT activity is a requirement for the diversification of immunoglobulin (Ig) and T-cell antigen receptor (TcR) genes. Thus, upon completion of Ig and TcR gene rearrangement PKC activation may mediate the programmed changes in these enzyme levels to those observed in mature lymphocytes. Fungalbionics implicates fungi and fungal metabolltes a s the cause of gout/hyperuricemia. The mechanlsms are not the usual patterns of invasive-type mycoses nor of mycotoxicoses, but rather incorporate occult features of both mechanisms. Gout and/or hyperurlcemia can be induced in fowl b y the mycotoxlns oosporein, ochratoxIn and b y oosporein-produclng fungl. Gouty tophl have been induced In primates b y aflatoxin. Fungi produce preformed uric acld, preformed urate crystals, lipoproteins, glycosaminoglycans and glutamatcs, excess of which a r e found in gout. Gouty tophi are granulomatous and possess all of the features of delayed hypersensltivlty. Giant cells in avian and human gouty tophi contain asteroid bodies which are fungal In origin. Fungal-like spherules have been found in avlan gouty lesions; cultural and immunological electron microscopy studles a r e In progress. The findings in acute gout are those of a n acute infection. All drugs used in treatlng gout/hyperuricemia are antifungal. Grlseofulvln, a n antifungal antlbiotlc, is a s effective a s colchlcine in gout. Both a r e antitubulins and arrest fungal cell division. Probenecid, allopurinol, cortlcosteroids, NSAIDS, possess antifungal activity. The fungalbionic concept gives a unitarian explanation of gout, hyperuricemia and related dlseases and findings. Risk scores rang4 f'mn 2 -15, with a mean value a e n - Complete deficiency of hypoxanthine guanine phosphoribosyltransferase causes the Lesch-Nyhan Syndrome (LNS). Partial deficiency of HPRT causes severe, precocious gout. The molecular basis for HPRT deficiency has been determined previously in this laboratory by amino acid sequence analysis in three suhjects and by cloning of mutant cDNA sequences in six subjects. In each case a single point mutation resulting in a single amino acid substitution was identified.
FUNGALBIONICB-A N E W CONCEPT OF T H E ETIOLOGY
The structural consequences of these mutations were examined using secondary structure prediction techniques. The mutations in HPRT-London and HPRT-Yale abolish putative 8-turns while the mutation in HPRT-Midland predicts an additional 8-turn.
A sequence predicted to be in random coil structure in WRTMunich and HPRT-Ashville is replaced by 6-sheet structure and a region of putative A-sheet in HPRT-Ann Arbor ia replaced by a-helix.
The predicted structural consequences of the mutations in HPRT-Flint, HPRT-Kinston, and HPRT-Toronto were unremarkable using these techniques. A new uricosuric agent, 5-chloro-7,8-dihydro-3-phenylfuro[2,3-gl-l,2-benzisoxazole-7-carboxylic acid (AA-193) was compared with other uricosurics in the rat, mouse and cebus monkey, because the effects of those drugs were known to be highly species-dependent.
Probenecid and tienilic acid which in the human kidney block the reabsorption of filtered and secreted urate, increased the urate excretion in rats. But benzbromarone, an inhibitor of the latter reabsorption in man, did not have the uricosuric act,ivity. Thus, the post-filtered reabsorption of urate is probably dominant in rats. We found that in rats AA-193 is the most potent uricosuric yet reported. In mice, probenecid not only had so-called paradoxical actions but stimulated the urinary urate wasting after administration ol pyrazinamide. Aspirin also responded paradoxically. These data suggested that the renal transport system of urate in the mouse is similar to that in man. AA-193 as well as benzbromarone enhanced the urate excretion dose-dependently in normal condition, but the effects were different in pyrazinamide-suppression tests in mice. In cebus monkeys, the uricosuri~ and hypouricemic effects of AA-193 were more putent than those of probenecid and similar to those of tienilic acid, but less than those of benzbromarone. Benzbromzrone had a considerable role in post-secreted raabsorption in the mokey.
Csnclusion: AA-19: is a new class of uricosuric agent that controls the renal reabsorption of filtrat~d urate particularly. THE LESCH-NYHAN SYNDROME. N. Lawrence Edwards, Dept 28 of Medicine, Univ of Florida and VAMC, Gainesville, Florida and Michael V. Johnston, and Faye S. Silverstein Dept of Neurology and Pediatrics, Univ of Xichigan, Ann Arbor, Michigan, USA. Cyclic nucleotides in the central nervous system may have "first" messenger roles as well as the classic "second" aessenger effects. Such primary actions may include regulation of neurotransmitter synthesis, control of certain cellular movements and effects on both tropic and developmental processes. Low cyclic AMP (CAMP) levels are reported in spinal fluids (CSF) from patients with certain basal ganglion diseases, i.e. Parkinson's and advanced Huntington's disease. Cyclic GMP ( c m ) in the CSF is felt to reflect central cholinergic activity. In an effort to find a suitable biochemical marker of disease activity in the Lesch-Nyhan syndrome (L-NS) we made serial measurements of cANP and cGMP on deproteinized CSF extracts using a radioimmunoassay. Three boys with L-NS at ages 29, 68, and 128 months had 5 CSF determinations over the subsequent 40 months period. Seventeen age-matched patients undergoing leukemia workup and showing no evidence of CNS disease were used as controls. The control group had values of 1.4 t 0.6 pmollml for CAMP and 0.1 t 0.05 for cGMP. The L-NS subjects had CAMP level of 4.3 t 2.1 and cGMP of 1.1 t 0.7. The correlation (Pearson's) between CAMP and cGMP levels in the L-NS subjects was r = 0.83 and in the controls only 0.26. These findings raise the possibility of an as yet undescribed CSF metabolite with caffeine-like activity in the L-NS spinal fluid that may block cyclic nucleotide phosphodiesterase activity and lead to CSF cyclic nucleotide elevations.
